153 related articles for article (PubMed ID: 3263418)
21. Distinction between antigen receptor and IL 2 receptor triggering events in the activation of alloreactive T cell clones with calcium ionophore and phorbol ester.
Albert F; Hua C; Truneh A; Pierres M; Schmitt-Verhulst AM
J Immunol; 1985 Jun; 134(6):3649-55. PubMed ID: 3921610
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 1-mediated activation of interleukin 4 (IL 4)-producing T lymphocytes. Proliferation by IL 4-dependent and IL 4-independent mechanisms.
Ho SN; Abraham RT; Nilson A; Handwerger BS; McKean DJ
J Immunol; 1987 Sep; 139(5):1532-40. PubMed ID: 3114369
[TBL] [Abstract][Full Text] [Related]
23. Activation of IL 1-dependent and IL 1-independent T cell lines by calcium ionophore and phorbol ester.
Zlotnik A; Daine B
J Immunol; 1986 Feb; 136(3):1033-7. PubMed ID: 3079793
[TBL] [Abstract][Full Text] [Related]
24. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S
Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354
[TBL] [Abstract][Full Text] [Related]
25. Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin/proteasome pathway in human fibroblasts.
Lee HW; Smith L; Pettit GR; Smith JB
Mol Pharmacol; 1997 Mar; 51(3):439-47. PubMed ID: 9058599
[TBL] [Abstract][Full Text] [Related]
26. Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy.
Alfaro-Bustamante F; Ramirez-Flores G; Gonzalez-Mendoza A; Islas-Rodriguez A; Fafutis-Morris M
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):73-9. PubMed ID: 9207756
[TBL] [Abstract][Full Text] [Related]
27. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
Tao X; Davis LS; Hashimoto K; Lipsky PE
J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
[TBL] [Abstract][Full Text] [Related]
28. Comparison of phorbol ester/calcium ionophore and phytohemagglutinin-induced signaling in human T lymphocytes. Demonstration of interleukin 2-independent transferrin receptor gene expression.
Kumagai N; Benedict SH; Mills GB; Gelfand EW
J Immunol; 1988 Jan; 140(1):37-43. PubMed ID: 3121740
[TBL] [Abstract][Full Text] [Related]
29. Dephosphorylation of activated protein kinase C contributes to downregulation by bryostatin.
Lee HW; Smith L; Pettit GR; Bingham Smith J
Am J Physiol; 1996 Jul; 271(1 Pt 1):C304-11. PubMed ID: 8760059
[TBL] [Abstract][Full Text] [Related]
30. Phorbol myristate acetate and calcium ionophore A23187-stimulated human T cells do not express high-affinity IL-2 receptors.
Chopra RK; Powers DC; Adler WH; Nagel JE
Immunology; 1989 Jan; 66(1):54-60. PubMed ID: 15493263
[TBL] [Abstract][Full Text] [Related]
31. Nordihydroguaiaretic acid blocks IL-2-independent lymphocyte proliferation and enhances responses to PPD.
Esa AH; Converse PJ
Scand J Immunol; 1996 Feb; 43(2):127-33. PubMed ID: 8633191
[TBL] [Abstract][Full Text] [Related]
32. Distinct modulatory effects of bryostatin 1 and staurosporine on the biosynthesis and expression of the HIV receptor protein (CD4) by T cells.
Boto WM; Brown L; Chrest J; Adler WH
Cell Regul; 1991 Feb; 2(2):95-103. PubMed ID: 1863603
[TBL] [Abstract][Full Text] [Related]
33. gamma-Interferon plays a key role in T-cell-induced tumor regression.
Tuttle TM; McCrady CW; Inge TH; Salour M; Bear HD
Cancer Res; 1993 Feb; 53(4):833-9. PubMed ID: 8428364
[TBL] [Abstract][Full Text] [Related]
34. Signals involved in T cell activation. I. Phorbol esters enhance responsiveness but cannot replace intact accessory cells in the induction of mitogen-stimulated T cell proliferation.
Davis L; Lipsky PE
J Immunol; 1985 Nov; 135(5):2946-52. PubMed ID: 3876369
[TBL] [Abstract][Full Text] [Related]
35. Human T cell activation by phorbol esters and diacylglycerol analogues.
Berry N; Ase K; Kikkawa U; Kishimoto A; Nishizuka Y
J Immunol; 1989 Sep; 143(5):1407-13. PubMed ID: 2474594
[TBL] [Abstract][Full Text] [Related]
36. A novel antigen (H47 Ag) on human lymphocytes involved in T cell activation.
Hirohashi N; Nakao M; Kubo K; Yamada A; Shichijo S; Hara A; Sagawa K; Itoh K
Cell Immunol; 1993 Dec; 152(2):371-82. PubMed ID: 8258145
[TBL] [Abstract][Full Text] [Related]
37. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
[TBL] [Abstract][Full Text] [Related]
38. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
[TBL] [Abstract][Full Text] [Related]
39. The 28-kDa/32-kDa activation antigen EA 1. Further characterization and signal requirements for its expression.
Bjorndahl JM; Nakamura S; Hara T; Jung LK; Fu SM
J Immunol; 1988 Dec; 141(12):4094-100. PubMed ID: 3264302
[TBL] [Abstract][Full Text] [Related]
40. The antineoplastic agent bryostatin-1 induces proinflammatory cytokine production in human monocytes: synergy with interleukin-2 and modulation of interleukin-2Rgamma chain expression.
Bosco MC; Rottschafer S; Taylor LS; Ortaldo JR; Longo DL; Espinoza-Delgado I
Blood; 1997 May; 89(9):3402-11. PubMed ID: 9129048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]